2Dondorp A M, Yeung S, White L, et al. Artemisinin resist- ance:current status and scenarios for containment [ J ]. Na- ture Reviews Microbiology, 2010,8 (4) : 272-280.
3Wang Huaimin, Wei Jun, Yang Chengbiao, et al. The inhi- bition of tumor growth and metastasis by self-assembled nanofibers of taxol [ J ]. Biomaterials ,2012,33 ( 24 ) : 5848- 5853.
4Chen Jian,McKay R M,Parada L F. Malignant glioma:les- sons from genomics, mouse models, and stem cells [ J ]. Cell,2012,149 ( 1 ) :36-47.
5Crespo-Ortiz M P, Wei Ming Q. Antitumor activity of arte- misinin and its derivatives:from a well-known antimalarial agent to a potential anticaneer drug[ J ]. J Biomed Biotech- no1,2012, doi : 10.1155/2012/247597.
6Zhang Jiali,Wang Zeng, Hu Wei,et al. DHA regulates an- giogenesis and improves the efficiency of CDDP for the treatment of lung earcinoma [ J ]. Mierovasc Res, 2013,87 : 14-24.
7Cabello C M, Lamore S D, Bair W B, et al. The redox anti- malarial dihydroartemisinin targets human metastatic mela- no-ma cells but not primary melanocytes with induction of NOXA-dependent apoptosis [ J ]. Invest New Drugs, 2012, 30(4) :1289-1301.
8Wen X, Lin Z Q, Liu B, et al. Caspase-mediated pro- grammed cell death pathways as potential therapeutic tar- gets in cancer[ J ]. Cell Prolif,2012,45 (3) :217-224.
9Anfosso L, Efferth T, Albini A, et al. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins[ J]. Pharmacogenomics ,2006,6 (4) :269-278.
10Ba Qian, Zhou Naiyuan, Duan Juan, et al. Dihydroartemisi- nin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1 [ J ]. PLoS One, 2012, 7 ( 8 ) : e42703.
